PlainRecalls
FDA Drug Low Class III Terminated

ACETAMINOPHEN and CODEINE PHOSPHATE ORAL SOLUTION USP, 120 mg/12 mg per 5 mL, packaged in a) 4 oz. (120 mL) bottles, NDC 0603-9013-54, UPC 3 0603-9013-54 8 and b) ONE PINT (473 mL) bottles, NDC 0603-9013-58, UPC 3 0603-9013-58 6, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811

Reported: January 14, 2015 Initiated: December 22, 2014 #D-0331-2015

Product Description

ACETAMINOPHEN and CODEINE PHOSPHATE ORAL SOLUTION USP, 120 mg/12 mg per 5 mL, packaged in a) 4 oz. (120 mL) bottles, NDC 0603-9013-54, UPC 3 0603-9013-54 8 and b) ONE PINT (473 mL) bottles, NDC 0603-9013-58, UPC 3 0603-9013-58 6, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811

Reason for Recall

Failed Impurities/Degradation Specifications: High out of specification results for the known impurity p-Aminophenol.

Details

Recalling Firm
Qualitest Pharmaceuticals
Units Affected
a) 3936 bottles; b) 84420 bottles
Distribution
Nationwide
Location
Huntsville, AL

Frequently Asked Questions

What product was recalled?
ACETAMINOPHEN and CODEINE PHOSPHATE ORAL SOLUTION USP, 120 mg/12 mg per 5 mL, packaged in a) 4 oz. (120 mL) bottles, NDC 0603-9013-54, UPC 3 0603-9013-54 8 and b) ONE PINT (473 mL) bottles, NDC 0603-9013-58, UPC 3 0603-9013-58 6, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811. Recalled by Qualitest Pharmaceuticals. Units affected: a) 3936 bottles; b) 84420 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: High out of specification results for the known impurity p-Aminophenol.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 14, 2015. Severity: Low. Recall number: D-0331-2015.